Indian pharmaceutical firm Ranbaxy has launched the drug Synriam, which it claims will prove a more efficient and simpler treatment for malaria. With its affordable price, Synriam may well be a step towards achieving the WHO’s goal of eradicating malaria by 2050, but Ranbaxy cannot take all the credit for it.
Ranbaxy launches new anti-malarial Synriam – Chemistry World, 3 May 2012
A list of main references for the article is here.
Akshat Rathi 